IGF1 and Cognitive impairment: One neuropsychological test found that in patients with type 2 diabetes combined with mild cognitive impairment, the serum IGF-1/IGFBP-3 concentration ratio was reduced, and the executive function of patients was significantly decreased (Huang et al., 2015).